Jordan Dunitz, MD

Associate Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine

Jordan Dunitz

Contact Info

Mailing Address:
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine
420 Delaware Street SE, MMC 276
Minneapolis, MN 55455

Administrative Assistant Name
PACCS

Administrative Phone
612-624-0999

Administrative Email
paccmed@umn.edu

Administrative Fax Number
612-625-2174

Associate Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine

Director, Minnesota Cystic Fibrosis Center and Adult CF Program

Medical Director, Center for Lung Science and Health Clinic


Pulmonologist and Critical Care Physician


SUNY Stony Brook Health Sciences Center School of Medicine, Stony Brook, NY

Internal Medicine Residency, University of Minnesota, Minneapolis, MN

Pulmonary and Critical Care Medicine Fellowship, University of Minnesota, Minneapolis, MN

Summary

My main clinical interests are cystic fibrosis (CF) and lung transplantation. I developed and direct the University of Minnesota Adult CF Program and am Director of our CF Center. In addition to CF, I am interested in the management of other bronchiectatic lung disease including Primary Ciliary Dyskinesia. I am involved in the pre-transplant evaluation and post-transplant management of patients referred for lung transplantation for both CF and other end-stage lung disease. My involvement in lung transplantation has led me to develop expertise in interventional bronchoscopy for both transplant-related and non-transplant airway disease. I am experienced in balloon dilation, and stent placement. In the in-patient arena I mainly focus on CF and lung transplantation, but also participate in general pulmonary consultation and all aspects of intensive care management. In addition to my direct patient care responsibilities, I participate actively in continuous clinical quality improvement activities in the Adult CF Program.

Awards & Recognition

  • Mpls St. Paul Magazine "Top Doctor" (2012-2015)
  • Best Doctors in America® (2011-2012, 2013)

Research

Research Summary/Interests

I have served as site Primary Investigator for a number of phase II and III trials for new medications for CF patients, including VX-770 and Denfosol. I have participated as a co-investigator for numerous other phase I-III trials for new CF and transplant medications as well.

I have also participated as a primary or co-investigator for a number of investigator-initiated clinical studies. I am an active participant in a number of collaborative studies at the University of MN CF Center, related to cystic fibrosis and lung transplantation.

Publications

  • Bellin MD, Laguna T, Leschyshyn J, Regelmann W, Dunitz J, Billings J, Moran A. Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study. Pediatr Diabetes. 14(6):417-21, 2013.
  • Lee JT, Gertz MI, Dunitz JM, Kelly RF, D’Cunha J, Whitson BA, Shumway SJ. The rise of Clostridium difficile infection in lung transplant recipients in the modern era. Clin Transplant. 27(2):303-10, 2013.
  • Browne RF, Willey-Courand DB, George C, McMullen A, Dunitz J, Slvia B, Perket E. Non-physician providers as clinical providers in cystic fibrosis: survey of U.S. programs. Pediatr Pulmon. 48(4):398-404, 2013.
  • Kempainen RR, Sajan JA, Pylkas AM, Dunitz JM, Rimell FL, Milla CE. Effect of endoscopic sinus surgery on pulmonary status of adults with cystic fibrosis. Otolaryngol Head Neck Surg. 147(3):557-62, 2012.
  • Dincer HE, Dunitz, JM. Tracheobronchopathia Osteochondroplastica and Selective IgA Deficiency. Journal of Bronchology & Interventional Pulmonology. 19(1): 54-56, 2012.
  • Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, Deboeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, Ordoñez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax. 67(1):12-8, 2012 Jan.
  • Best C, Brearley A, Gaillard P, Regelmann W, Billings J, Dunitz J, Phillips J, Holme B, Schwarzenberg SJ. A Pre-Post Retrospective Study Of Patients With Cystic Fibrosis And Gastrostomy Tubes. J Pediatr Gastroenterol Nutr. 53(4):453-8, 2011 Oct.
  • Wudhikarn K, Holman CJ, Linan M, Blaes AH, Dunitz JM, Hertz ME, Peterson BA. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota. Clin Transplant. 2010 Nov 16. Epub ahead of print. PMID: 21077949
  • Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW, Donaldson SH, Moss RB, Pilewski JM, Rubenstein RC, Uluer AZ, Aitken ML, Freedman SD, Rose LM, Mayer-Hamblett N, Dong Q, Zha J, Stone AJ, Olson ER, Ordoñez CL, Campbell PW, Ashlock MA, Ramsey BW. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010;363(21):1991-2003.PMID:
  • Sabati AA, Kempainen RR, Milla CE, Ireland M, Schwarzenberg SJ, Dunitz JM, Khan KM. Characteristics of gastroesophageal reflux in adults with cystic fibrosis. J Cyst Fibros. 2010 Sep;9(5):365-70. Epub 2010 Jul 31. PMID: 20674518

Clinical

Specialties

  • Pulmonology

Clinics

Center for Lung Science and Health;Transplant Center

Clinical Interests

Cystic fibrosis; Lung transplantation; Primary ciliary dyskinesia; Bronchiectasis; Interventional bronchoscopy